Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$20.45 - $26.49 $149,019 - $193,032
-7,287 Reduced 1.08%
664,672 $14.4 Million
Q4 2023

Feb 07, 2024

BUY
$19.02 - $30.13 $2.22 Million - $3.52 Million
116,804 Added 21.04%
671,959 $14.9 Million
Q3 2023

Nov 07, 2023

BUY
$30.46 - $46.04 $583,339 - $881,712
19,151 Added 3.57%
555,155 $16.9 Million
Q2 2023

Aug 10, 2023

SELL
$31.57 - $37.73 $642,638 - $768,031
-20,356 Reduced 3.66%
536,004 $20 Million
Q1 2023

May 09, 2023

BUY
$29.72 - $41.45 $12.4 Million - $17.3 Million
417,287 Added 300.05%
556,360 $17.8 Million
Q4 2022

Feb 07, 2023

BUY
$30.23 - $38.71 $3.31 Million - $4.24 Million
109,459 Added 369.62%
139,073 $4.96 Million
Q3 2022

Nov 09, 2022

BUY
$22.51 - $38.27 $13,280 - $22,579
590 Added 2.03%
29,614 $862,000
Q2 2022

Aug 10, 2022

BUY
$20.97 - $37.47 $608,633 - $1.09 Million
29,024 New
29,024 $650,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.42B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.